CJ
ABBV icon

Caitlin John’s AbbVie ABBV Stock Holding History

Caitlin John’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$37.6K Hold
149
– – 0.02% 402
2026
Q1 		$32.3K Buy
149
+9
+6% +$2K 0.02% 359
2025
Q4 		$32K Sell
140
-4
-3% -$911 0.02% 371
2025
Q3 		$33.3K Buy
+144
New +$29.3K 0.02% 316
2025
Q1 		– Sell
-168
Closed -$29.9K – 131
2024
Q4 		$29.9K Buy
168
+40
+31% +$7.35K 0.02% 309
2024
Q3 		$21.9K Buy
128
+36
+39% +$6.72K 0.01% 373
2024
Q2 		$15.7K Buy
92
+1
+1% +$166 0.01% 386
2024
Q1 		$16.5K Sell
91
-3
-3% -$517 0.01% 385
2023
Q4 		$14.6K Buy
+94
New +$13.7K 0.01% 381

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Caitlin John's ABBV Position: Q2 2026 in Review

Caitlin John held its AbbVie (ABBV) position steady in Q2 2026 at 149 shares worth $37.6K. The position accounts for 0.02% of the portfolio, ranked #402.

Caitlin John first reported a position in ABBV in Q4 2023 and has held it in 9 quarters since. 4,215 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Caitlin John held 149 shares of AbbVie worth $37.6K as of Q2 2026.
  • Caitlin John left its AbbVie share count unchanged in Q2 2026.
  • AbbVie made up 0.02% of Caitlin John's portfolio in Q2 2026, its #402 holding.
  • Caitlin John first reported a position in AbbVie in Q4 2023 and has held it in 9 quarters since.
  • 4,215 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Caitlin John's 13F filing for Q2 2026, filed 17 Aug 2026.